The peptide problem: Hype is outrunning the evidence RFK Jr pushes for FDA approval of BPC 157 peptide Eric Topol, MD posted on the topic LinkedIn FDA Targets GLP 1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York RFK Jr. and the Perils of Peptides Washington Monthly Is BPC 157 Banned? Oral vs. Injectable Forms Explained